N
Neowiz
KOSDAQ:095660
Neowiz
KOSDAQ:095660
Price:
19 800
KRW
0.1%
Market Closed
Market Cap:
419.1B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Neowiz
19800
+20 (+0.1%)
| 52 Week Range |
17 830
27 300
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Neowiz
Balance Sheet
Balance Sheet Decomposition
Neowiz
Neowiz
| Current Assets | 302.8B |
| Cash & Short-Term Investments | 253.6B |
| Receivables | 39.3B |
| Other Current Assets | 9.9B |
| Non-Current Assets | 348.9B |
| Long-Term Investments | 89B |
| PP&E | 89.6B |
| Intangibles | 137B |
| Other Non-Current Assets | 33.4B |
| Current Liabilities | 77.5B |
| Accounts Payable | 39.8B |
| Accrued Liabilities | 3.3B |
| Other Current Liabilities | 34.4B |
| Non-Current Liabilities | 69.1B |
| Long-Term Debt | 3.1B |
| Other Non-Current Liabilities | 66B |
Balance Sheet
Neowiz
Neowiz
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
41 593
|
62 764
|
66 529
|
63 637
|
89 510
|
85 931
|
171 728
|
113 407
|
91 697
|
129 872
|
|
| Cash Equivalents |
41 593
|
62 764
|
66 529
|
63 637
|
89 510
|
85 931
|
171 728
|
113 407
|
91 697
|
129 872
|
|
| Short-Term Investments |
89 292
|
71 481
|
14 670
|
10 344
|
29 887
|
72 721
|
43 390
|
118 848
|
120 514
|
111 757
|
|
| Total Receivables |
63 035
|
129 311
|
109 830
|
39 707
|
26 993
|
28 783
|
25 693
|
29 126
|
23 701
|
43 553
|
|
| Accounts Receivables |
34 015
|
34 296
|
23 523
|
24 547
|
21 725
|
23 225
|
23 408
|
26 431
|
21 210
|
36 725
|
|
| Other Receivables |
29 020
|
95 015
|
86 307
|
15 160
|
5 268
|
5 558
|
2 285
|
2 695
|
2 490
|
6 828
|
|
| Inventory |
254
|
8
|
5
|
11
|
14
|
23
|
23
|
22
|
32
|
122
|
|
| Other Current Assets |
5 755
|
3 828
|
5 592
|
75 095
|
8 557
|
3 904
|
7 530
|
10 514
|
17 603
|
12 307
|
|
| Total Current Assets |
199 929
|
267 392
|
196 627
|
188 794
|
154 961
|
191 362
|
248 363
|
271 917
|
253 547
|
297 611
|
|
| PP&E Net |
5 375
|
3 514
|
4 894
|
6 152
|
51 207
|
81 986
|
85 804
|
84 893
|
88 754
|
91 373
|
|
| PP&E Gross |
5 375
|
3 514
|
4 894
|
6 152
|
51 207
|
81 986
|
85 804
|
84 893
|
88 754
|
91 373
|
|
| Accumulated Depreciation |
34 693
|
31 847
|
32 936
|
29 806
|
29 740
|
31 584
|
34 357
|
30 515
|
21 494
|
20 562
|
|
| Intangible Assets |
19 781
|
7 504
|
7 660
|
4 869
|
3 270
|
4 361
|
11 563
|
42 067
|
44 910
|
70 931
|
|
| Goodwill |
12 467
|
0
|
0
|
11 347
|
11 347
|
11 571
|
13 723
|
38 019
|
34 276
|
78 506
|
|
| Note Receivable |
20 030
|
70
|
9 947
|
10 268
|
3 146
|
2 705
|
2 670
|
2 426
|
2 360
|
2 847
|
|
| Long-Term Investments |
72 502
|
74 828
|
78 369
|
62 730
|
124 341
|
90 522
|
96 501
|
117 257
|
117 345
|
99 557
|
|
| Other Long-Term Assets |
93 251
|
21 062
|
19 942
|
20 200
|
18 441
|
15 494
|
20 729
|
18 112
|
18 896
|
30 604
|
|
| Other Assets |
12 467
|
0
|
0
|
11 347
|
11 347
|
11 571
|
13 723
|
38 019
|
34 276
|
78 506
|
|
| Total Assets |
423 334
N/A
|
374 371
-12%
|
317 439
-15%
|
304 359
-4%
|
366 712
+20%
|
398 002
+9%
|
479 352
+20%
|
574 691
+20%
|
560 087
-3%
|
671 429
+20%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
8 322
|
9 812
|
9 142
|
7 551
|
9 032
|
8 473
|
10 488
|
10 213
|
7 155
|
10 834
|
|
| Accrued Liabilities |
8 504
|
8 739
|
8 552
|
9 378
|
16 229
|
11 298
|
12 834
|
15 217
|
15 386
|
31 185
|
|
| Short-Term Debt |
980
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
270
|
60 053
|
287
|
88
|
0
|
2 560
|
2 359
|
2 112
|
20 008
|
19 985
|
|
| Other Current Liabilities |
35 216
|
24 557
|
23 210
|
15 722
|
25 627
|
22 597
|
32 198
|
39 660
|
44 787
|
51 212
|
|
| Total Current Liabilities |
53 292
|
103 161
|
41 192
|
32 738
|
50 888
|
44 927
|
57 879
|
67 203
|
87 336
|
113 217
|
|
| Long-Term Debt |
79 376
|
359
|
96
|
0
|
0
|
2 315
|
6
|
18 717
|
647
|
3 504
|
|
| Deferred Income Tax |
229
|
253
|
85
|
74
|
0
|
55
|
800
|
4 977
|
3 023
|
6 837
|
|
| Minority Interest |
1 042
|
758
|
628
|
1 057
|
386
|
5 838
|
8 125
|
9 568
|
9 686
|
38 189
|
|
| Other Liabilities |
5 601
|
6 310
|
5 011
|
6 799
|
16 985
|
21 827
|
25 051
|
14 919
|
10 325
|
20 250
|
|
| Total Liabilities |
139 539
N/A
|
109 326
-22%
|
45 756
-58%
|
38 554
-16%
|
68 258
+77%
|
74 961
+10%
|
91 861
+23%
|
115 384
+26%
|
111 017
-4%
|
181 997
+64%
|
|
| Equity | |||||||||||
| Common Stock |
10 958
|
10 958
|
10 958
|
10 958
|
10 958
|
10 958
|
11 017
|
11 017
|
11 017
|
11 017
|
|
| Retained Earnings |
210 659
|
190 326
|
200 576
|
198 457
|
229 434
|
251 743
|
310 762
|
365 967
|
380 995
|
428 204
|
|
| Additional Paid In Capital |
132 410
|
132 410
|
126 245
|
126 245
|
126 245
|
126 245
|
129 989
|
129 989
|
129 989
|
129 989
|
|
| Unrealized Security Profit/Loss |
624
|
709
|
199
|
295
|
52
|
144
|
144
|
144
|
141
|
2 003
|
|
| Treasury Stock |
12 874
|
12 647
|
20 628
|
20 353
|
17 621
|
15 152
|
13 915
|
21 861
|
40 117
|
50 055
|
|
| Other Equity |
57 980
|
56 710
|
45 668
|
49 796
|
50 509
|
50 608
|
50 218
|
25 661
|
32 673
|
31 727
|
|
| Total Equity |
283 796
N/A
|
265 045
-7%
|
271 683
+3%
|
265 806
-2%
|
298 454
+12%
|
323 040
+8%
|
387 491
+20%
|
459 307
+19%
|
449 070
-2%
|
489 432
+9%
|
|
| Total Liabilities & Equity |
423 334
N/A
|
374 371
-12%
|
317 439
-15%
|
304 359
-4%
|
366 712
+20%
|
398 002
+9%
|
479 352
+20%
|
574 691
+20%
|
560 087
-3%
|
671 429
+20%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
22
|
22
|
21
|
21
|
21
|
21
|
22
|
21
|
21
|
20
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
